Exploring the MSL role in IITs (Investigator Initiated Trials)
In this episode, Gail Rosen Spahn joins to delve into Investigator-Initiated Trials (IITs) and their significance in the MSL landscape. The discussion covers the definition and understanding of IIT programs, the responsibilities of MSLs and investigators, and the role of sales reps. The conversation touches on derisking strategies and pre-commercial considerations, assessing ROI, and enhancing MSL engagement through IITs. Gail shares insights on communicating effectively, managing milestones, and navigating potential pitfalls in IIT funding. The episode wraps up with reflections on the benefits of IITs for MSLs, a sponsor mention, and a listener appreciation segment.
My guest today is Gail Rosen Spahn, Medical Affairs Leader, and Consultant. Gail shares insights regarding the MSL role and Investigator Initiated Trials.
Gail shares…
👉 What an IIT program is
👉 How a company can set up an IIT program
👉 What the role of the MSL is in supporting IITs
👉 How an IIT program helps to drastically improve KOL engagement
👉 What companies and MSLs can get out of it
